"Poor people would be able to get cheaper health services with the use of generic drugs as branded drugs were being sold at exorbitant prices, beyond reach of the poor," he said in a statement issued here.
Appreciating the initiative taken by doctors of the state to promote the use of these drugs, he said, "We need to bring a practical revolution for the use of generic drugs."
He said there was a huge variation between prices of branded and generic medicines but it should be ensured by the government that medicines should be provided at cheaper rates to the common man on priority basis.
Kumar said that India is a leading player in the generics drug market and exports around 45,000 crore to 200 countries in the world.
Even institutions like UNICEF were meeting 60 per cent of their requirements of drugs from the Indian market since 2006-07 and seven domestic pharma companies were acquired by foreign players at highly over valued prices, he said.
"As per the survey by a panel, a specific branded drug for the treatment of cancer was sold to more than Rs 1 lakh but a generic cancer drug manufactured in India is available only for Rs 8,000," he noted.
Kumar said the World Health Organisation has found that generic medicine are available only in 20 to 40 per cent government hospitals and people are forced to go to private shops which patronise branded medicines which are very costly.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
